A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Why is this study being done?The I-CARE 2 study is looking for unpaid caregivers of community-dwelling individuals living with dementia to test a technological intervention. The purpose of the study is to test the effects of a smart phone application on alleviating caregiver burden and improving the behavioral and psychological …
We propose to study cells obtained from the upper nose in patients with clinically diagnosed Alzheimer Disease or related dementia, and amyotrophic lateral sclerosis. There is evidence that cells from the nose may show changes associated to these neurological illnesses. The study of cells from normal subjects is necessary for …
What is the purpose of this study?The purpose of this program is to identify, evaluate, study, and follow persons who have Alzheimer's disease, those who have other disorders of memory and thinking, and older individuals who have normal memory and thinking.
What is the purpose of this study?Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) Study has been to validate biomarkers for Alzheimer's disease (AD) clinical trials. ADNI4 continues the previously funded ADNI1, ADNI-GO, ADNI2, and ADNI3 studies that have combined public/private collaborations between …
What is the purpose of this study?The overall goal of this project is to validate a novel performance-based IADL instrument that uses a smartphone to assess healthcare-related daily activities, ASSET. This IADL test has been designed to tap the high-level tasks that challenge seniors in daily life, to serve as …
This study will evaluate the effects of the use of a program to reduce prescribing of a group of commonly prescribed medications called anticholingerics that may adversely effect cognitive functioning in older adults.
What is the purpose of this study?To assess the safety, tolerability, biomarker, cognitive, and clinical efficacy of investigational products in participants with an Alzheimer's disease-causing mutation by determining if treatment with the study drug improves disease-related biomarkers and slows the rate of progression of cognitive or clinical impairment.THIS STUDY IS …
What is the purpose of this study?The primary objective of this study is to collect data on the penetration of commercially available, FDA approved, extended-release niacin into the spinal fluid. One dose of 500 mg nicotinic acid will be used (in addition to placebo) to build a dose response curve …
